Difference between revisions of "Hancock S"
From Bioblast
Beno Marija (talk | contribs) |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 5: | Line 5: | ||
The Children's Hospital of Philadelphia | The Children's Hospital of Philadelphia | ||
|city=Philadelphia | |||
|state=Pennsylvania (PA) | |||
|country=USA | |||
|info=[[IOC61]] | |info=[[IOC61]] | ||
}} | }} | ||
| Line 11: | Line 14: | ||
|info=[[IOC61]] | |info=[[IOC61]] | ||
}} | }} | ||
== Participated at== | == Participated at== | ||
::::* [[IOC61]] | ::::* [[IOC61| IOC61 Schroecken AT]] | ||
Latest revision as of 17:51, 12 February 2018
| Name | Hancock Saege, |
|---|---|
| Institution | Center for Mitochondrial and Epigenomic Medicine (CMEM)
The Children's Hospital of Philadelphia |
| Address | , |
| City | Philadelphia |
| State/Province | Pennsylvania (PA) |
| Country | USA |
| Weblink | |
| O2k-Network Lab | US PA Philadelphia Wallace DC |
Labels:
Field of research: Basic
Publications
Add references to your publications
Abstracts
| Published | Reference | |
|---|---|---|
| Picard 2014 Abstract MiP2014 | 2014 | Quantitative regulation of nuclear gene expression by mitochondrial DNA heteroplasmy. |
